ACUTE MYELOGENOUS LEUKEMIA
Clinical trials for ACUTE MYELOGENOUS LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ACUTE MYELOGENOUS LEUKEMIA trials appear
Sign up with your email to follow new studies for ACUTE MYELOGENOUS LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Personalized vaccine trial aims to train immune system to fight leukemia after transplant
Disease control OngoingThis early-stage trial is testing the safety of a personalized cancer vaccine for people with acute myeloid leukemia (AML) who have recently received a stem cell transplant. The vaccine is made by fusing the patient's own immune cells with their leukemia cells, aiming to teach th…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA
Phase: PHASE1 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New transplant method opens door for more blood cancer patients
Disease control OngoingThis trial is testing a stem cell transplant method that uses donors who are not a perfect genetic match. It aims to help adults and children with various blood cancers, like leukemia and lymphoma, when a fully matched donor isn't available. The study will see if this approach, w…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA
Phase: PHASE2 • Sponsor: Center for International Blood and Marrow Transplant Research • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Vaccine trial aims to train immune system to fight leukemia relapse
Disease control OngoingThis study is testing a cancer vaccine to see if it can help prevent acute myeloid leukemia (AML) from coming back after successful chemotherapy. The vaccine is made by combining a patient's own immune cells with their leukemia cells, aiming to teach the body's immune system to r…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA
Phase: PHASE2 • Sponsor: Beth Israel Deaconess Medical Center • Aim: Disease control
Last updated Apr 02, 2026 14:56 UTC
-
New pill tested for Tough-to-Treat leukemias
Disease control TerminatedThis study is testing a new oral drug called CA-4948 (emavusertib) for adults with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) that has come back or hasn't responded to prior treatments. The main goals are to find the safest and most effective dose an…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Curis, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:30 UTC
-
Scientists gather cancer clues to build future weapons
Knowledge-focused ENROLLING_BY_INVITATIONThis study collects blood or bone marrow samples from people with blood cancers like leukemia and lymphoma. Researchers will study these samples in the lab to better understand how these cancers work and to find new targets for future treatments. The study does not test a new the…
Matched conditions: ACUTE MYELOGENOUS LEUKEMIA
Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Apr 03, 2026 14:41 UTC